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a b s t r a c t
Background: Children with severe acute malnutrition (SAM), with or without diarrhoea, often have enteropathy,
but there are few molecular data to guide development of new therapies.
We set out to determine whether SAM enteropathy is characterised by speciﬁc transcriptional changes which
might improve understanding or help identify new treatments.
Methods: We collected intestinal biopsies from children with SAM and persistent diarrhoea. mRNA was extracted
from biopsies, sequenced, and subjected to a progressive set of complementary analytical approaches: NOIseq,
Gene Set Enrichment Analysis (GSEA), and correlation analysis of phenotypic data with gene expression.
Findings: Transcriptomic proﬁles were generated for biopsy sets from 27 children of both sexes, under 2 years of
age, of whom one-third were HIV-infected. NOIseq analysis, constructed from phenotypic group extremes, revealed 66 differentially expressed genes (DEGs) out of 21,386 mapped to the reference genome. These DEGs include genes for mucins and mucus integrity, antimicrobial defence, nutrient absorption, C-X-C chemokines,
proteases and anti-proteases. Phenotype – expression correlation analysis identiﬁed 1221 genes related to villus
height, including increased cell cycling gene expression in more severe enteropathy. Amino acid transporters and
ZIP zinc transporters were speciﬁcally increased in severe enteropathy, but transcripts for xenobiotic
metabolising enzymes were reduced.
Interpretation: Transcriptomic analysis of this rare collection of intestinal biopsies identiﬁed multiple novel elements of pathology, including speciﬁc alterations in nutrient transporters. Changes in xenobiotic metabolism
in the gut may alter drug disposition. Both NOIseq and GSEA identiﬁed gene clusters similar to those differentially
expressed in pediatric Crohn's disease but to a much lesser degree than those identiﬁed in coeliac disease.
Fund: Bill & Melinda Gates Foundation OPP1066118. The funding agency had no role in study design, data collection, data analysis, interpretation, or writing of the report.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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LPS
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differentially expressed genes
gene set enrichment analysis
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Malnutrition in children in low- and middle-income countries persists on a huge scale [1]. Stunting, impaired linear growth, affects 159
million children, 24% of all the world's children [1]. Wasting is less
common, but severe acute malnutrition (SAM) represents a medical
emergency. Optimal treatment of SAM in the community is associated
with mortality rates around 4% per episode but once medical complications supervene in-hospital mortality climbs to 10%–40% [2–4]. Children with SAM and persistent diarrhoea have particularly high
mortality rates, as do children with SAM and HIV5. Counterintuitively, malnutrition does not fully respond to nutritional therapy.
Stunting rates can only be reduced by 15% at most even with
optimally-delivered nutritional care [6] or sanitation [7,8]. Wasting

https://doi.org/10.1016/j.ebiom.2019.06.015
2352-3964/© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2. Methods
Research in context
Evidence before this study
Children in Africa and Asia with severe acute malnutrition (SAM)
complicated by overt infectious disease (diarrhoea, measles,
pneumonia) have continuing unacceptably high mortality rates.
Several lines of evidence implicate intestinal dysfunction in driving
mortality. A systematic search revealed very few studies which
have analysed the small intestinal mucosa to identify pathophysiological processes which could contribute to adverse outcomes.
Added value of this study
In this study of 27 children with SAM and persistent diarrhoea,
RNA sequencing was used to correlate transcriptomic profiles
with phenotypic measures of intestinal dysfunction, including villus height, circulating lipopolysaccharide concentrations,
lactulose:rhamnose ratio, and circulating IgG antibodies to
deamidated gliadin peptides. Differentially expressed genes and
gene sets included amino acid and zinc transporters, mucosal protection molecules, cell proliferation genes, chemokines, and xenobiotic metabolising enzymes.
Implications of all the available evidence
While previous studies of intestinal dysfunction in severe malnutrition have drawn attention to mucosal abnormalities, including increased permeability, unsupervised transcriptomic analysis has
revealed specific alterations in physiological processes which
could inform the search for improved therapy for this lifethreatening disorder.

(SAM) is associated with high relapse rates following discharge [9].
There are three major possible explanations for why improved nutrition is insufﬁcient to treat malnutrition. First, insufﬁcient care after
discharge from SAM treatment may result in inadequate supplementary feeding. Community-based management of acute malnutrition
should overcome this [10,11]. Second, children return to the same environment from which they came so economic, parenting, and environmental factors continue to play an adverse role. Third, there may
be some speciﬁc biological obstacle to recovery which renders nutritional therapy ineffective, or only partially effective. We recently demonstrated that in SAM there is severe small intestinal enteropathy,
characterised by villus blunting, leakiness, microbial translocation,
and mucosal and systemic inﬂammation [12]. Evidence from Malawi
also indicates that intestinal damage plays a central role in mortality
in SAM [3].
Older studies indicated that enteropathy is severe in children with
SAM [13,14], but few studies have been informed by tissue investigation due to the considerable difﬁculties in obtaining biopsy material
ethically. Here we report the results of a transcriptomic analysis of
the same children whose biopsies we characterised in a previous report [12]. The mRNA proﬁle of these biopsies shows consistent patterns across several domains of pathology, highlighting several
important cross-cutting themes related to mucus layer integrity, antimicrobial defence, nutrient transporters, protease/anti-protease balance, xenobiotic metabolism, and immune activation, among others.
Because samples such as these are difﬁcult to obtain, and we do not
consider it justiﬁable to collect biopsies from healthy children, the
analysis which follows compares more severe enteropathy against
less severe.

Children were recruited from the malnutrition ward of the University Teaching Hospital, Lusaka. This ward treats children with severe
acute malnutrition with medical complications, while uncomplicated
SAM is treated in the community [11]. Consequently, these children
have severe disease and mortality rates have historically been high
[15], in common with many other similar centres in Africa [3,5,16]. Up
to one half of the children on this ward have HIV infection at any one
time [15], which further increases risk of mortality [5,15]. Children
were recruited on the basis that they had SAM complicated by persistent diarrhoea, and that initial investigations had revealed nothing to
explain their clinical state. Parents/guardians of all eligible children
were invited to participate, and b10% declined. Written, informed consent was obtained from parents and caregivers in all cases. Ethics approval was obtained from the University Biomedical Research Ethics
Committee on 11th April 2013, reference number 006–01-13.

2.1. Investigations
Children with SAM, with or without HIV and with or without oedema, whose parents or guardians had given written consent,
underwent endoscopy under sedation with a Pentax EG2490k gastroscope (external diameter 8 mm). Biopsies were collected from the distal
duodenum as previously reported [12]. Prior to withdrawal of the endoscope, a test solution containing 1 g lactulose and 0.2 g rhamnose in
20 ml was ﬂushed down the working channel into the duodenum.
Blood collected on the day of endoscopy was used for measurement of
lipopolysaccharide (LPS), LPS binding protein (LBP), intestinal fatty
acid binding protein (FABP), soluble CD14 (sCD14) and CD163 as previously described [12]. Urine was collected after 60–120 min for lactulose:
rhamnose (LR) ratio analysis using mass spectrometry [17], as a measure of permeability.

2.2. Assessment of inter-biopsy variability
In 13 pairs of biopsies the individual biopsies could be retrieved from
the cryo-storage vials and were individually sequenced. These were
analysed separately to assess inter-biopsy variation, but then mRNAs
were pooled in silico particularly for the analysis of differential
expression.

2.3. RNA sequencing
Two small intestinal biopsies were immediately snap-frozen in liquid nitrogen prior to storage at -80 °C. RNA was extracted using Trizol
reagents (Invitrogen, Carlsbad, CA) followed by silica column puriﬁcation (RNeasy Mini Kit, Qiagen) and quantiﬁed using a Nanodrop spectrophotometer (ND-2000c, Thermo Scientiﬁc, USA), prior to transport
to the Beijing Genomics Institute (BGI). RNA quality control was performed using an Agilent 2100 Bioanalyser and ABI StepOnePlus RealTime PCR System. For RNA sequencing preparation, the total RNA was
treated with DNase I followed by mRNA enrichment using oligo-dT labelled beads and ligation of sequencing adaptors to the enriched
mRNA fragments. RNA sequencing was carried out using an Illumina
HiSeq2000 platform with 50 bp reads. Filtering steps included removing
reads with adapters, removing reads in which unknown bases were
N10%, and removing low quality reads (percentage of low quality
bases over 50%). The proportion of clean reads was never b99%, usually
N99.6%. After low-quality reads were removed and adapter sequences
trimmed 3.3 billion clean reads were obtained, with an average of 165
million reads per sample.
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2.4. Principal component analysis
Principal Component Analysis (PCA) (Partek Software) was carried
out on the FPKM values of all genes with a median value N1.0 across
all samples to establish the similarity of replicate samples collected
from a single subject.
2.5. Deﬁnition of group extremes for categorical analysis
It was not possible to identify a group of children to act as controls
from whom biopsies could ethically be collected, thus extremes of the
ranges were compared across several measurements (i.e severe vs
mild enteropathy). Measurement of villus height, LR ratio, LPS and circulating antibodies to deamidated gliadin peptides (anti-DGP) were as
previously reported [12]. For each variable, the study cohort was divided into quartiles, with approximately the same number in each quartile but depending on the distribution of values which were sometimes
close together. The highest and lowest quartiles were used as the extreme groups. A group with short villi (n = 7) was deﬁned as b180
μm, and a group with long villi (n = 8) deﬁned as N230 μm. A group
with high LR ratio (n = 6) was deﬁned as N0.25, and a group with low
LR ratio (n = 6) deﬁned as b0.2. A group with high plasma LPS (n =
8) was deﬁned as N300 EU/ml, and a group with low LPS (n = 6) as
b120 EU/ml. A group with higher anti-DGP (n = 7) was deﬁned as
N8 U/ml, and a group with low anti-DGP (n = 8) was deﬁned as
b1.5 U/ml.
2.6. Transcriptomic analysis - gene expression and differential expression
Gene expression levels and differentially expressed genes (DEGs)
were identiﬁed in an independent analysis at the Beijing Genomics Institute. Expression levels were quantiﬁed by Expectation Maximization
(RSEM) software and expressed in Fragment Per Kilobase of transcript
per Million (FPKM). Differentially expressed genes (DEGs) were identiﬁed between group extremes, deﬁned as above, using NOIseq [18] analysis. Using log2-fold change, a heatmap was then constructed from
these groups, including only those genes with probability of difference
of 0.8 or more.
2.7. Phenotypic correlation analysis
The enteropathy phenotypes assessed included average villus
height, LR ratio, circulating lipopolysaccharide levels, and circulating
IgG anti-DGP levels. Additionally, age, history of breastfeeding, and
HIV status were examined. Enteropathy phenotypes were correlated
against the RNAseq gene expression data using Spearman's rank correlation and were ﬁltered for signiﬁcance using a correlation p-value of p
b 10−6 and a Spearman's correlation coefﬁcient (ρ) ≥0.4 or ≤−0.4.
Genes with a maximum FPKM b10.0 were not considered for further
functional analysis.
2.8. Biological process and pathway analysis
DEGs were manually grouped according to known function in the
small intestine using KEGG, Reactome and GeneCards databases. In addition, networkanalyst™/DAVID was employed to annotate DEGs according to KEGG and Reactome. Results were plotted in R version
3.3.1. Protein-protein interactions networks (ﬁrst-order) among the
DEGs were constructed with networkanalyst™ using the InnateDB
with a conﬁdence score cutoff of 900. The nodes and edges generated
were then edited in Gephi version 0.91. Furthermore, functional class
scoring was carried out using Gene Set Enrichment Analysis (GSEA
v3.0 Beta 2) software from the Broad Institute. Gene expression data between groups and genes from the phenotype correlation analyses were
compared against Hallmark gene sets of Molecular Signature Database

(MSigDB) using signal to noise metric ranking for gene sets and permuted 100 times by phenotype class.
2.9. Data sharing
Annotated datasets are available on request from the corresponding
author.
3. Results
Transcriptomic proﬁling was carried out on biopsy sets from 27 children with SAM of both sexes, under 2 years of age, of whom one-third
were HIV-infected (Table 1).
3.1. Characterization of mild and severe domain groups
Characteristics of the groups constructed at the extremes of the selected domains (villus height, circulating endotoxin, permeability, and
anti-deamidated gliadin peptide) are shown in Supplementary
Table S1. These groups demonstrated very little overlap (Supplementary Fig. S1). For example, groups widely separated by villus height do
not differ appreciably in terms of systemic inﬂammatory or bacterial
translocation markers (Table S1).
3.2. Principal component analysis (PCA) of repeat and singleton biopsies,
and HIV
PCA analysis was performed on all samples, repeat and singleton,
utilizing all genes with a median FPKM ≥1.0 across the sample. A total
of 40.3% of the variation was described in the ﬁrst two components of
the analysis and as can be seen in Fig. 1A. While several of the biopsies
exhibited a degree of variation in either the ﬁrst or the second component, only subject p17 appeared to have substantial variation across
both of the ﬁrst two components. Viewing demographic data overlaid
onto the map suggested that age differences were roughly associated
with approximate grouping of subject samples across component 1
(Fig. 1B), and HIV had minimal inﬂuence on the observed variation
(Fig. 1C).
3.3. NOISeq identiﬁcation of DEGs in enteropathy within domain groups
NOIseq analysis identiﬁed 66 signiﬁcantly differentially expressed
genes (DEGs), of 21,386 mapped to the reference genome, using a probability of difference cut-off of 0.8 or more (Fig. 2). The manual functional
classiﬁcation of these DEGs (Fig. 2) reveals gene groups that are implicated in mucus biology, antimicrobial defence, protease/anti-protease
balance, CXC chemokine secretion, B cell function, and serum amyloid
A. Further analysis of some of these functional groups is described
below. Of note, the pattern of changes differed for LPS to that seen in
the other domains (VH, LR ratio, anti-DGP). It is also striking that the
magnitude of the change was greater for non-coding transcripts. Further analysis with Network analyst revealed predicted interactions of
these DEGs with each other and with other genes with they are closely
associated in the literature (Supplementary Figs. S7-S10). NOIseq analysis comparing HIV-infected and uninfected children with SAM found
41 differentially expressed genes (Supplementary Table S2).
3.4. Phenotypic correlation analysis
As described in the methods a correlative analysis was performed for
each of the domains, without grouping, to account for the continuous
nature of the data. A non-parametric Spearman analysis identiﬁed
1221 genes correlated with VH; 3043 correlated with LR ratio (permeability); and 1491 associated with anti-DGP IgG with p b 10−6. Correlation with circulating LPS demonstrated fewer signiﬁcant genes (269),
nearly an order of magnitude less. Given the much larger number of

M. Chama et al. / EBioMedicine 45 (2019) 456–463

459

Table 1
Clinical and demographic characteristics of children with SAM.
Characteristic

Sex (M:F)
Age (months)
HIV seropositive
Current breastfeeding
WAZ
LAZ
WLZ
VH (μm)
LPS (EU/ml)
L:R ratio
Anti-DGP IgG
Lactase deﬁciency

By sex

By HIV serological status

Male n = 16

Female n = 11

P

HIV seronegative n = 18

HIV seropositive n = 9

P

–
14 (10,19)
5
3
−3.4 (−5.1,−2.5)
−2.5 (−3.8,−2.0)
−2.8 (−4.0,−1.7)
216 (143,247)
339 (57,556)
0.289 (0.170, 1.000)
2.5 (1.5, 8.6)
5/12 (42%)

–
19 (12,21)
4
0
−3.6 (−4.7,−2.7)
−3.0 (−4.4,−1.6)
−2.8 (−4.2,−1.0)
215 (164,246)
183 (120,267)
0.189 (0.104, 0.401)
2.9 (1.4, 20.7)
2/5 (40%)

–
0.21
1.00
0.25
0.98
0.92
0.92
0.96
0.45
0.23
0.89
1.00

11:7
15 (11,20)
–
1
−3.2 (−4.0,−2.7)
−2.5 (−3.7,−1.7)
−2.7 (−3.5,−1.4)
202 (153,247)
272 (142,600)
0.213 (0.129, 0.289)
1.6 (1.6, 3.6)
6/13 (46%)

5:4
12 (10,21)
–
2
−4.6 (−5.0,−3.3)
−3.8 (−5.5,−2.3)
−2.8 (−4.4,−2.5)
225 (175,243)
120 (0.223)
0.762 (0.357, 1.000)
26.0 (5.1, 45.7)
1/4 (25%)

1.00
0.88
–
1.00
0.16
0.22
0.35
0.85
0.06
0.23
0.005
0.60

Continuous variables are shown as median (interquartile range). LPS, lipopolysaccharide; VH, villus height.

highly correlated genes with the phenotypic domains as compared to
DEGs identiﬁed via predeﬁned groups based on ﬁxed cutoffs, GSEA analysis was employed to provide a comprehensive overview of the key processes correlated either positively or negatively with the subject values
(Fig. 3). Again, highly signiﬁcant processes and pathways associated
with multiple domains included cell-cycle/proliferation, immune cell
activity, absorptive mechanisms, mucosal barrier, and xenobiotic
metabolism.

3.5. Cell-cycle and proliferation associated genes
Among the list of key processes and pathways identiﬁed by GSEA as
correlated with LR ratio and inversely with VH are multiple entries associated with cell cycle and proliferation (Fig. 3). The number and directionality of these genes, which included proliferating cell nuclear
antigen, cyclins, cyclin-dependent kinases and p53 related transcripts
(Supplementary Fig. S2) suggest that malnutrition enteropathy is a
hyper-proliferative (hyperplastic) rather than atrophic enteropathy.
3.6. Dysregulation of immune responses
In view of past studies suggesting that environmental enteropathy is
related to T cell activation (and hyperproliferation) [19–21], and NOIseq
data implicating immune pathways (Figs. 2 and 3), we interrogated
GSEA results to identify immunological genes demonstrating correlation with VH, LR, LPS, and anti-DGP IgG. A range of genes were identiﬁed
that represent a broad range of immune responses, including
chemokines, cytokines, antigen presentation and immune cell markers
(Supplementary Fig. S3). However, few signiﬁcant correlations were observed with LPS.
3.7. Dysregulation of absorptive mechanisms
Given that the principal function of the intestine is nutrient absorption, we analysed transcripts for known solute carriers (SLC genes) to
search for correlations with VH or LR. The majority of mitochondrial
transporters (SLC family 25 family) were positively correlated with VH
and negatively with permeability and therefore consistent with expected changes in enterocyte mass. In contrast, a broad range of
amino acid transporters were inversely correlated with VH and positively with permeability, suggesting speciﬁc up-regulation (Supplementary Fig. S4). The ZIP family of zinc transporters, with the
exception of ZIP-4, followed the pattern of the amino acid transporters,
as did one choline and one riboﬂavin transporter (Fig. S4). However, the
bidirectional zinc transporter ZnT-5, which is expressed at the apical
membrane, exhibited the pattern consistent with enterocyte mass (i.e.
positively correlated with VH).

3.8. Mucosal barrier disruption
To explore further the prior hypothesis that mucus barrier disruption is a feature of severe enteropathy (reference 21, Fig. 2 and Supplementary Figs. S7 and S10) we examined mucus constituents, goblet cell
transcription factors, and host defence peptides. The majority of these
transcripts demonstrated increased expression in more severe enteropathy: inverse correlation with VH and direct correlation with permeability (Supplementary Fig. S5). As with the NOIseq analysis, the
pattern of correlation with circulating LPS was not entirely consistent
with the pattern of correlation with other domains of pathology. Tight
junction and gap junction molecules were distinctly underrepresented in the signiﬁcant correlations identiﬁed (Fig. S5). Occludin,
ZO-1, E-cadherin and β-catenin were not represented in the database of
correlated gene transcripts.
3.9. Globally reduced expression of genes for xenobiotic metabolism in severe enteropathy
Genes encoding enzymes required for xenobiotic metabolism demonstrated broad, consistent direct correlations with VH and inverse correlations with LR (Fig. 2; Supplementary Fig. S6), consistent with
reduced expression in severe enteropathy.
4. Discussion
We carried out a transcriptomic analysis of small intestinal samples
taken from Zambian children being treated for SAM in the University
Teaching Hospital, Lusaka, Zambia. We undertook this work in the
hope that we would gain new insights into pathophysiology, and that
we would identify new therapeutic targets. The ﬁrst analysis of our
data using NOIseq identiﬁed 66 differentially expressed genes which
fall into several functional groups, including nutrient transporters, enzymes for xenobiotic metabolism, and genes with important roles in
the integrity of the mucus barrier. A correlative approach identiﬁed an
order of magnitude more transcripts and a much broader range of implicated gene products. For some gene sets there was a surprisingly
high degree of consistency in correlations with VH and LR ratio. Our
data are consistent with previous evidence that environmental/malnutrition enteropathy in Africa is a hyperplastic enteropathy characterised,
perhaps driven, by immune activation [19–21]. However, additional evidence beyond mRNA analysis is required to establish that this is really
the case in children with SAM. If this is correct, we can only speculate on
how malnutrition is sensed in the gut, whether by mTOR or by intestinal
cell kinase [22]. A recent faecal transcriptomic study from Malawi also
implicated immune activation (HLADR, CD53, TNF) and mucosal protection (MUC12, S100A8 and Reg1A) [21]. The changes in immune genes
are not those which would be expected to be associated with major
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Fig. 1. Principal Component Analysis of transcriptomes of Zambian children with Severe Acute Malnutrition. (A) pairs of duplicate biopsies from the same child, taken on the same day, are
ringed; only one pair shows a difference in both components between biopsies from the same child. (B) the inﬂuence of age on transcriptomes. (C) the inﬂuence of HIV on the transcriptome, showing no discernible pattern.

inﬁltrations of neutrophils or eosinophils, and were not strongly related
to LPS, our biomarker of microbial translocation.
It is of considerable interest that several sets of genes showed an apparently speciﬁc up-regulation, such as that noted for amino acid and
zinc transporters. Some transporters, such as mitochondrial transporters, were positively correlated with VH, which we believe signiﬁes
that expression levels of these enzymes reﬂect enterocyte mass, not
necessarily gene expression change. The inverse correlations observed
for plasma membrane amino acid transporters suggests speciﬁc differential regulation, and that enterocytes have responded to greater
amino acid demand, or reduced availability, or both. We interpret the
general increase in ZIP proteins in the same way, though the functions
of different ZIP proteins are complex, and ZIP-4 has been shown to be
up-regulated in zinc deﬁciency [23]. Its correlation here is of interest because these children were all being given supplementary zinc as part of

the nutritional rehabilitation they were undergoing. ZnT-5 is potentially
a bidirectional transporter located at the enterocyte luminal surface
[23], so the signiﬁcance of its negative correlation with permeability remains uncertain, as does the physiological impact of altered zinc transporter expression. Of course, as this is an analysis of mRNA only,
increased gene expression may signify either up-regulation as part of
pathophysiology or a compensatory response to increased protein degradation or shedding. Further work is needed to clarify the physiological
consequences of the transcriptional changes we have identiﬁed.
There was considerable overlap between the NOIseq transcriptomic
proﬁle in SAM (Fig. 2) and that previously reported by RNA sequencing
in children with IBD [24]. In SAM enteropathy and in Crohn's disease
there was increased expression of DUOX2, DUOXA2, lipocalin 2,
CEACAM 5 and 7, MUC1, SAA 1, 2 and 4, and CXCL5 genes (Supplementary Figs. S2–5, S7 and S10), and these transcripts were further over-
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Fig. 2. Differentially expressed genes identiﬁed by NOIseq analysis. Heat map of 66 differentially expressed. Colours represent the log2 –fold change in more severe enteropathy (short villi,
high lactulose permeation, high plasma lipopolysaccharide, and higher blood anti-deamidated gliadin peptide concentration).
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Fig. 3. Pathway correlations with measures of enteropathy: (A) villus height, (B) permeability measured as lactulose:rhamnose (LR) ratio, (C) anti-deamidated gliadin peptide IgG, and
(D) circulating LPS as a marker of translocation.

expressed in HIV infection (Supplementary Table S2). We conducted a
systematic search for transcriptomic studies in IBD and found 3 studies
in children and four in adults, mostly by microarray (Supplementary
table S3). DUOX, MUC, S100 and Reg families were signiﬁcantly increased in IBD in four of these studies (Table S3). MUC1 is a
membrane-bound mucin [25,26] with widespread expression, including small intestine. DUOX2 is required for synthesis of thyroid hormone,
but it also generates reactive oxygen species which play a role in mucosal defence [27]. It is induced by TNFα and MDP and protects against infection with Listeria monocytogenes [28]. It also mediates the induction
of mucins by epidermal growth factor (EGF) [29]. Reactive oxygen species synthesised by NADPH oxidases (including DUOX2) reduce virulence in Campylobacter jejuni [30]. Serum amyloid A (SAA) proteins
include three isoforms: 1, 2 and 4 (SAA3 is a pseudogene) and they
act as acute phase reactants [31] in Crohn's disease and many other inﬂammatory disorders. Despite the morphological similarity between severe EE and early coeliac disease, their transcriptomic proﬁles
demonstrate limited overlap. In an analysis of peripheral blood mononuclear cells in coeliac disease, interferon-γ and BACH2 were identiﬁed
as central to the gene expression changes [32]. In another study, DEGs
included CD19, CD203c, HLAE, DEFA5, IFNG, and IL18 [33]. In contrast,
these were not dominant DEGs in SAM enteropathy.
Another readily identiﬁable functional cluster relates to antimicrobial protection of the mucosa. DEFA6 encodes human defensin 6, a
Paneth cell product with antimicrobial properties due to its ability to enmesh bacteria [34]. DEFB4A encodes human β-defensin 2, an antimicrobial peptide expressed at mucosal surfaces which is inducible during
inﬂammation but which we have previously reported to be expressed
only at low levels in environmental enteropathy [35]. Reg 1A & B and
Reg 3A are related antimicrobial peptides with predominant distribution in the pancreas and small intestine (Paneth cells) respectively

[36,37]. Lactoferrin possesses antibacterial properties through sequestration of Fe, an important bacterial nutrient, and through interruption
of dsRNA genomes [38]. MSMB is fungicidal.
Principal components analysis shows that, although there is variation in gene expression proﬁles between biopsies taken from the same
child on the same day, paired biopsies from one child are much closer
together than biopsies from different children. This may be of importance for future work. Although it seems that one single biopsy does
represent the transcriptional proﬁle of that individual's mucosa at that
point in time, there was considerable variability and it would be desirable to include more than one biopsy in any transcriptomic experiment.
HIV was not the focus of this study, but HIV infected children are at
much higher risk of complicated SAM and therefore are overrepresented in a group of children such as this. The transcriptional
changes attributable to HIV suggest that in addition to the higher expression of certain genes (including NADPH oxidases) there is even
higher expression in HIV infection. We know that there is a functionally
important mucosal immune defect in these children as their response to
treatment for cryptosporidiosis is dramatically impaired [39]. However,
the nature of that defect is not clear [40]. Our data suggest that HIV induces additional inﬂammation on top of that induced by SAM, and alters
protease secretion. There are also clear signals from genes which are not
well understood, including gastrokines.
Our ﬁndings, though based on a small number of children, may suggest novel therapeutic approaches to encourage mucosal healing in SAM.
Enhancement of mucus integrity and antimicrobial defence may be
worthwhile avenues for future research. Immune activation has long
been recognised as a mediator of enteropathy [19,20], and suppression
of T cell activation using a mucosal immunosuppressant needs to be evaluated in a clinical trial. Further analysis of our data, available from the authors, may reveal additional novel targets for development of therapies.
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